Global Retirement Partners’s Galectin Therapeutics GALT Stock Holding History

Global Retirement Partners’s Portfolio GALT Stock Details GALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16K	Buy	+250	New	+$648	﹤0.01%	4166
2025 Q4	$1.04K	Hold	250	–	–	﹤0.01%	3880
2025 Q3	$1.06K	Hold	250	–	–	﹤0.01%	3514
2025 Q2	$528	Buy	+250	New	+$374	﹤0.01%	3570
2024 Q4	$323	Hold	250	–	–	﹤0.01%	3460
2024 Q3	$688	Hold	250	–	–	﹤0.01%	3226
2024 Q2	$565	Hold	250	–	–	﹤0.01%	3274
2024 Q1	$598	Hold	250	–	–	﹤0.01%	3094
2023 Q4	$455	Hold	250	–	–	﹤0.01%	3105
2023 Q3	$510	Hold	250	–	–	﹤0.01%	2950
2023 Q2	$360	Sell	250 -100	-29%	-$170	﹤0.01%	3019
2023 Q1	$588	Hold	350	–	–	﹤0.01%	2887
2022 Q4	$396	Hold	350	–	–	﹤0.01%	2808
2022 Q3	$0	Hold	350	–	–	﹤0.01%	2789
2022 Q2	$0	Hold	350	–	–	﹤0.01%	2746
2022 Q1	$0	Buy	+350	New	+$677	﹤0.01%	2678
2021 Q4	–	Sell	-250	Closed	-$1K	–	820
2021 Q3	$1K	Hold	250	–	–	﹤0.01%	1889
2021 Q2	$1K	Hold	250	–	–	﹤0.01%	1796
2021 Q1	$1K	Hold	250	–	–	﹤0.01%	1710
2020 Q4	$1K	Hold	250	–	–	﹤0.01%	1673
2020 Q3	$1K	Sell	250 -1,000	-80%	-$2.8K	﹤0.01%	1558
2020 Q2	$4K	Sell	1,250 -450	-26%	-$1.13K	﹤0.01%	1331
2020 Q1	$3K	Sell	1,700 -500	-23%	-$1.22K	﹤0.01%	1330
2019 Q4	$6K	Hold	2,200	–	–	﹤0.01%	1286
2019 Q3	$8K	Hold	2,200	–	–	﹤0.01%	1169
2019 Q2	$9K	Buy	+2,200	New	+$9.53K	﹤0.01%	1134

Other funds holding GALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

WANY

Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Global Retirement Partners's GALT Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Galectin Therapeutics (GALT) in Q2 2026: 250 shares worth $1.16K. The stake represents ﹤0.01% of the portfolio and ranks #4166 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in GALT as recently as Q4 2025.

Global Retirement Partners first reported a position in GALT in Q2 2019 and has held it in 26 quarters since. The position peaked at $9K in Q2 2019. 98 funds tracked by Wall St. Rank hold GALT as of Q2 2026.

Global Retirement Partners held 250 shares of Galectin Therapeutics worth $1.16K as of Q2 2026.
Galectin Therapeutics was a new Global Retirement Partners position in Q2 2026.
Galectin Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4166 holding.
Global Retirement Partners first reported a position in Galectin Therapeutics in Q2 2019 and has held it in 26 quarters since.
Global Retirement Partners's Galectin Therapeutics position peaked at $9K in Q2 2019.
98 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.